|
Evolving from life sciences to biopharmaceuticals, Alseres Pharmaceuticals is a biotechnology company engaged in the research and clinical development of biopharmaceutical products for the diagnosis and treatment of Central Nervous System disorders. Alseres shares a commitment to find a better solution and make it available to those who need it most. ALTROPANE molecular imaging agent, in phase 3 clinical development, is a diagnostic tool intended to aid in differentiating Parkinsonian tremors from non-Parkinsonian or Essential Tremor using SPECT imaging. Alseres also has an ongoing nerve repair clinical development program for a product
candidate, Cethrin, in acute spinal cord injury. Visit Alseres Pharmaceuticals for an overview of ALTROPANE-PD.
|